Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.157
Filter
1.
Med. infant ; 30(2): 181-190, Junio 2023. ilus, tab
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1443731

ABSTRACT

Las pruebas de función tiroidea (PFT) son esenciales para el diagnóstico preciso y el seguimiento eficaz de la disfunción tiroidea. Existe un incremento progresivo y estable de los pedidos de PFT, incluso se han incorporado las mismas a los exámenes de salud anuales en niños sanos. Representan más del 60% de las pruebas realizadas en el laboratorio de endocrinología, tanto en adultos como en los laboratorios especializados en pediatría. Para hacer un uso eficiente de las PFT, antes de solicitarlas debemos preguntarnos… ¿Para quién? ¿Cuándo solicitarlas? ¿Qué pruebas solicitar? ¿Cómo solicitarlas? y ¿Cómo interpretar correctamente los resultados? Un resultado anormal en las PFT no siempre implica patología tiroidea asociada. Las PFT tienen importante variabilidad intra e interindividual lo que hace más compleja su correcta interpretación. La pesquisa de enfermedad tiroidea neonatal es un importante aporte a la prevención de la deficiencia mental en la infancia, su aplicación obligatoria posibilita un diagnóstico temprano, para asegurar su éxito debe considerarse en el marco de un programa integral de detección con estrategias de confirmación, tratamiento temprano y seguimiento a corto, mediano y largo plazo. No debe hacerse un uso indiscriminado de la prueba de estímulo con TRH en el diagnóstico de la patología tiroidea. En pediatría la estrategia de tamiz de enfermedad tiroidea es conveniente realizarla mediante la medición de por lo menos TSH y T4 libre e incluir la determinación de ATPO en grupos de riesgo, a diferencia de la determinación aislada de TSH como es recomendado en adultos. (AU)


Thyroid function tests (TFTs) are essential for accurate diagnosis and effective monitoring of thyroid dysfunction. There is a progressive and steady increase in requests for TFTs, and they have even been incorporated into annual health examinations in healthy children. They represent more than 60% of the tests performed in the endocrinology laboratory, both in adults and in specialized pediatric laboratories. To efficiently use TFTs, before requesting them we should ask ourselves... For whom? When to request them? Which tests to request? How to request them? and How to correctly interpret the results? An abnormal TFT result does not always imply thyroid disease. TFTs have significant intra- and inter-individual variability, which makes their correct interpretation more complex. Screening for newborn thyroid disease is an important contribution to the prevention of intellectual disability in childhood and its mandatory use enables early diagnosis; however, to ensure the test to be successful, it should be considered within the framework of a comprehensive screening program with strategies for confirmation, early treatment, and short-, medium-, and long-term follow-up. The TRH stimulation test in the diagnosis of thyroid disease should not be used indiscriminately. In children, the screening strategy for thyroid disease should be performed by measuring at least TSH and free T4 and include the measurement of TPO-ab in risk groups, as opposed to the isolated measurement of TSH as recommended in adults. (AU)


Subject(s)
Humans , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Autoimmune Diseases/diagnosis , Thyroid Function Tests/trends , Thyroid Function Tests/statistics & numerical data , Thyrotropin/blood , Diagnostic Techniques, Endocrine/trends , Hyperthyroidism/diagnosis , Hypothyroidism/diagnosis , Unnecessary Procedures
2.
Evid. actual. práct. ambul ; 26(2): e007052, 2023. tab
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1510036

ABSTRACT

El hipotiroidismo primario, caracterizado por una disminución en la síntesis de hormonas tiroideas, es el trastorno endocrinológico más frecuente, y la levotiroxina, el tratamiento de elección. Usualmente se recomienda su administración por la mañana, una hora antes del desayuno. A partir de la consulta de una paciente con dificultades para la adherencia ala toma de la medicación en ayunas, la autora de este artículo lleva a cabo una búsqueda bibliográfica para revisar la evidencia que avala la administración de levotiroxina antes de acostarse. (AU)


Primary hypothyroidism, characterized by a decrease in the synthesis of thyroid hormones, is the most common endocrine disorder, and levothyroxine being the treatment of choice. Its administration is usually recommended in the morning, one hour before breakfast. Based on the consultation of a patient with difficulties in sticking to taking medication on an empty stomach, the author of this article carried out a bibliographic search to review the evidence that supports the administrationof levothyroxine before bedtime. (AU)


Subject(s)
Humans , Female , Middle Aged , Thyroxine/administration & dosage , Treatment Adherence and Compliance , Hypothyroidism/drug therapy , Meta-Analysis as Topic , Treatment Outcome , Patient Preference
3.
Ghana med. j ; 57(1): 37-42, 2023. figures, tables
Article in English | AIM | ID: biblio-1427100

ABSTRACT

Objectives: This study aimed to examine possible associations between previously undiagnosed subclinical hypothyroidism and short-term outcomes and mortality in a sample of Iraqi patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Design: This is a prospective observational cohort study. Setting: The study was conducted in a single tertiary referral centre in Baghdad, Iraq. Participants: Thyroid-stimulating hormone and free T4 levels were measured in 257 patients hospitalised with STelevation myocardial infarction who underwent primary percutaneous coronary intervention between January 2020 and March 2022. Main outcome measures: Adverse cardiovascular and renal events during hospitalisation and 30-day mortality were observed. Results: Previously undiagnosed subclinical hypothyroidism was detected in 36/257 (14%) ST-elevation myocardial infarction patients and observed more commonly in females than males. Patients with subclinical hypothyroidism had significantly worse short-term outcomes, including higher rates of suboptimal TIMI Flow (< III) (p =0.014), left ventricular ejection fraction ≤ 40% (p=0.035), Killip class >I (p=0.042), cardiogenic shock (p =0.016), cardiac arrest in the hospital (p= 0.01), and acute kidney injury (p= 0.044). Additionally, 30-day mortality was significantly higher in patients with subclinical hypothyroidism (p= 0.029). Conclusion: Subclinical hypothyroidism previously undiagnosed and untreated had a significant association with adverse short-term outcomes and higher short-term mortality within 30 days compared to euthyroid patients undergoing primary percutaneous coronary intervention. Routine thyroid function testing during these patients' hospitalisation may be warranted.


Subject(s)
Humans , Thyroid Function Tests , Percutaneous Coronary Intervention , Hypothyroidism , Asymptomatic Infections , ST Elevation Myocardial Infarction , Access to Primary Care
5.
Rev. Bras. Saúde Mater. Infant. (Online) ; 22(2): 227-235, Apr.-June 2022. tab, graf
Article in English | LILACS | ID: biblio-1387181

ABSTRACT

Abstract Objectives: to determine the effectiveness of medical therapy in reducing complications associated with subclinical hypothyroidism during pregnancy. Methods: in 2021, a systematic review of available cohort studies was carried out in three databases, with no publication date limit. Study selection and data extraction were performed in duplicate. Random-effects meta-analysis was performed, and odds ratios were calculated, with the corresponding 95% confidence intervals. Cohort risk of bias was assessed using the Newcastle-Ottawa Scale (NOS). The certainty of the evidence was assessed using the GRADE methodology. Results: five studies were included for qualitative and quantitative synthesis. A statistically significant relationship was found between medical treatment in pregnant women with subclinical hypothyroidism with respect to spontaneous abortion (p=0.03; OR=0.77; CI95%=0.61-0.97), and no statistically significant relationship was found for delivery preterm (p=0.46; OR=1.11; CI95%=0.85-1.44), nor for abrupt placentae (p=0.56; OR=1.60; CI95%=0.33-7.66). Three studies were at moderate risk of bias, and two were at low risk of bias. In all the results the certainty was very low. Conclusions: medical treatment of subclinical hypothyroidism during pregnancy can have a beneficial effect in reducing cases of spontaneous abortion.


Resumo Objetivos: determinar la efectividad de la terapia médica para disminuir las complicaciones asociadas al hipotiroidismo subclínico durante la gestación. Métodos: en el 2021 se realizó una revisión sistemática de estudios de cohortes disponibles en tres bases de datos, sin límite de fecha de publicación. La selección de estudios y extracción de datos se realizaron por duplicado. Se realizó metaanálisis de efectos aleatorios y se calcularon los Odds ratio, con los correspondientes intervalos de confanza al 95%. El riesgo de sesgo de las cohortes se evaluó mediante la escala de Newcastle-Ottawa (NOS). La certeza de la evidencia se evaluó con la metodología GRADE. Resultados: cinco estudios fueron incluidos para síntesis cualitativa y cuantitativa. Se encontró una relación estadísticamente significativa del tratamiento médico en gestantes con hipotiroidismo subclínico con respecto al aborto espontáneo (p=0,03; OR=0,77; IC95%=0,61-0.97), no se encontró relación estadísticamente significativa para parto pre término (p=0.46; OR=1,11; IC95%=0.85-1.44), ni para abrupto placentae (p=0.56; OR=1,60; IC95%=0.33-7.66). Tres estudios tenían riesgo moderado de sesgo, y dos tenían riesgo de sesgo bajo. En todos los resultados la certeza fue muy baja. Conclusiones: el tratamiento médico del hipotiroidismo subclínico durante la gestación puede tener un efecto beneficioso para reducir los casos de aborto espontaneo.


Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications/prevention & control , Thyroxine/therapeutic use , Hypothyroidism/therapy , Abortion, Spontaneous , Abruptio Placentae , Obstetric Labor, Premature
6.
Univ. salud ; 24(1): 102-107, ene.-abr. 2022. tab, graf
Article in Spanish | LILACS, COLNAL | ID: biblio-1361191

ABSTRACT

Introducción: La enfermedad de cambios mínimos es una causa rara de síndrome nefrótico en el adulto, y su relación con el hipotiroidismo es más rara aún. Se considera que esta patología renal responde favorablemente al manejo con glucocorticoides y tiene una baja frecuencia de resistencia. Su abordaje hoy en día es objeto de investigación. Objetivo: Describir una rara etiología de síndrome nefrótico en el adulto con presentación, tratamiento y desenlace infrecuentes. Presentación del caso: Paciente femenino de 53 años quien inicia con síndrome nefrótico por enfermedad de cambios mínimos cortico-resistente y su asociación con un hipotiroidismo descontrolado, quien requiere manejo con rituximab y control de la enfermedad endocrinológica asociada, como enfermedad de base. Conclusiones: En este caso clínico se muestra como las enfermedades citadas pueden coexistir y el tratamiento en conjunto es necesario. El establecimiento de nuevas terapias en la población adulta como el rituximab podría mostrar beneficio, como en este caso. Sin embargo, aún existe la necesidad de estudios de mayor evidencia que validen firmemente la efectividad de los diferentes tratamientos en este tipo de pacientes.


Introduction: Minimal change disease is a rare cause of nephrotic syndrome in adults, and its association with hypothyroidism is even more exceptional. This renal pathology is considered to respond favorably to glucocorticoid management and has a low resistance frequency. How to approach this disease is currently under investigation. Objective: To describe a rare etiology of adult nephrotic syndrome with unusual presentation, treatment, and outcome. Case presentation: A 53 years-old female patient who initially experienced nephrotic syndrome due to steroid-resistant minimal change disease, which was also associated with uncontrolled hypothyroidism. She required management with rituximab and control of the associated endocrinological disease, which was considered as the underlying disease. Conclusions: This clinical case shows (i) how the two aforementioned diseases can coexist and (ii) that a joint treatment is necessary. Establishing new therapies may be beneficial for adult populations, such as the benefits seen in this case with the use of rituximab. However, further studies are needed to strongly validate the effectiveness of the different treatments for these types of patients.


Subject(s)
Humans , Middle Aged , Thyroid Diseases , Nephrosis , Hypothyroidism , Nephrosis, Lipoid , Nephrotic Syndrome
7.
Rev. cuba. endocrinol ; 33(1)abr. 2022.
Article in Spanish | LILACS-Express | LILACS, CUMED | ID: biblio-1408267

ABSTRACT

Introducción: A pesar de su baja incidencia, la gravedad del cuadro clínico y la alta mortalidad hacen del coma mixedematoso una complicación a tener en cuenta. Objetivo: Describir los elementos básicos para el diagnóstico y manejo terapéutico del coma mixedematoso en el paciente adulto. Métodos: Se realizó una búsqueda de literatura relevante sobre el tema. Se utilizaron buscadores de información científica como Pubmed y Google Académico. La estrategia de búsqueda incluyó los siguientes términos como palabras clave: hipotiroidismo primario, hipotiroidismo subclínico, diagnóstico y tratamiento. Fueron evaluados artículos de revisión, de investigación y páginas web que tuvieran menos de 10 años de publicados. Se consideraron los textos en idioma español e inglés y que hicieran referencia específicamente al tema de estudio a través del título. Fueron excluidos los artículos que no cumplieron con estas condiciones. Esto permitió el estudio de 64 artículos, de los cuales 40 fueron referenciados. Conclusiones: Para el diagnóstico del coma mixedematoso en el paciente adulto lo más importante es sospecharlo en aquellas personas que presenten factores precipitantes, acompañados de síntomas y signos de hipotiroidismo severo con diferentes grados de insuficiencia del sistema nervioso central, hipotermia, hipoventilación, insuficiencia circulatoria e hiponatremia. A esto se sumaría el escenario humoral característico y los posibles hallazgos dependientes de la enfermedad causante del hipotiroidismo. Se debe tratar con un reemplazo agresivo de levotiroxina sódica (vía endovenosa u oral, según posibilidades), unido a otras medidas de apoyo en el entorno hospitalario(AU)


Introduction: Despite its low incidence, the severity of the clinical picture and the high mortality make myxedematous coma a complication to be taken into account. Objective: Describe the basic elements for the diagnosis and therapeutic management of myxedematous coma in adult patients. Methods: A search of relevant literature on the subject was carried out. Pubmed and Google Scholar were used as search engines for scientific information. The search strategy included the following keyword terms: primary hypothyroidism, subclinical hypothyroidism, diagnosis and treatment. Review articles, research articles and Web pages that, in general, had less than 10 years of publication, in Spanish and English that specifically referred to the subject of study through the title were evaluated. Articles that did not meet these conditions were excluded. This allowed the study of 64 articles, of which 40 were referenced. Conclusions: For the diagnosis of myxedematous coma in the adult patient, the most important thing is to suspect it in those people who present precipitating factors, accompanied by symptoms and signs of severe hypothyroidism with different degrees of central nervous system insufficiency, hypothermia, hypoventilation, circulatory insufficiency and hyponatremia. To this would be added the characteristic humoral scenario and the possible findings dependent on the disease causing hypothyroidism. It should be treated with an aggressive replacement of levothyroxine sodium (intravenous or oral way, accodring to the possibilities), together with other supportive measures in the hospital setting(AU)


Subject(s)
Humans , Thyroxine/therapeutic use , Precipitating Factors , Hypothyroidism/diagnosis , Review Literature as Topic , Databases, Bibliographic , Search Engine , Hypothyroidism/therapy
8.
Med. leg. Costa Rica ; 39(1)mar. 2022.
Article in Spanish | LILACS-Express | LILACS, SaludCR | ID: biblio-1386304

ABSTRACT

Resumen El hipertiroidismo transitorio posterior a un trauma de cuello es un hecho infrecuente. Se presenta el caso de una femenina de 23 años, quien sufrió un accidente de tránsito presentando trauma en cuello al golpearse con la manivela de una motocicleta, posteriormente presentó supresión de TSH y elevación de T4 circulante, con ultrasonido y TAC que descartaron hematomas o rupturas de la glándula, que luego de manejo conservador presentó normalización de las hormonas tiroideas y evolucionó sin secuelas. Se hizo una revisión de la literatura sobre tiroiditis e hipertiroidismo transitorio post trauma de cuello.


Abstract Transient hyperthyroidism after neck trauma is not common. The case of a 23-year-old female is presented, who suffered a traffic accident presenting trauma to the neck when hitting with the crank of a motorcycle, subsequently presented suppression of TSH and elevation of circulating T4, with ultrasound and CT that ruled out bruises or ruptures of the gland, which after conservative management presented normalization of thyroid hormones and evolved without sequelae. A review of the literature on thyroiditis and transient hyperthyroidism after neck trauma was conducted.


Subject(s)
Humans , Female , Adult , Neck Injuries , Hypothyroidism/diagnosis , Accidents, Traffic
9.
Rev. cuba. med ; 61(1)mar. 2022.
Article in Spanish | LILACS-Express | LILACS, CUMED | ID: biblio-1408975

ABSTRACT

Introducción: El hipotiroidismo subclínico se relaciona con alteraciones cardiovasculares como la aterosclerosis carotidea subclínica por daños endoteliales como consecuencia de varios factores siendo el grosor intima-media carotideo (GIMC) un marcador reconocido, cuya elevación se menciona con frecuencia asociada a esta disfunción tiroidea. Objetivo: Determinar los efectos del tratamiento sustitutivo de pacientes con hipotiroidismo subclínico en el GIMC. Métodos: Se realizó un estudio de intervención que incluyó 94 pacientes con diagnóstico de hipotiroidismo subclínico sin tratamiento sustitutivo, que acudieron a la consulta de Endocrinología del hospital 10 de octubre a los cuales se les realizó determinación de TSH, colesterol total, colesterol LDL, colesterol HDL, triglicéridos y se les realizó US carotideo al inicio del estudio y al año de logrado el estado eutiroideo con tratamiento sustitutivo, para establecer diferencias en los parámetros evaluados antes y después del tratamiento sustitutivo. Resultados: Previo al tratamiento se encontró hipercolesterolemia en el 87,2 por ciento de los pacientes e hipertrigliceridemia en y 38,3 por ciento, mientras que, que valores elevados de colesterol LDL y disminuidos de colesterol HDL fueron hallados en el 55,3 por ciento y 19,3 por ciento de los mismos, el GIMC se mostró dentro del rango de normalidad. Tras el tratamiento con levotiroxina todos los valores medios de los parámetros estudiados se modificaron excepto en el caso de los triglicéridos Conclusiones: El tratamiento sustitutivo del hipotiroidismo subclínico tiene efectos beneficiosos sobre el GIMC, lo que pudiera ser secundario, entre otros factores, a la mejoría del perfil lipídico(AU)


Introduction: Subclinical hypothyroidism is related to cardiovascular alterations such as subclinical carotid atherosclerosis due to endothelial damage as a consequence of various factors, carotid intima-media thickness (CIMT) being a recognized marker, whose elevation is frequently mentioned in association with this thyroid dysfunction. Objective: To determine the effects of replacement therapy in patients with subclinical hypothyroidism in CIMT. Methods: An intervention study was carried out in 94 patients diagnosed with subclinical hypothyroidism, who did not have substitutive treatment. They were treated in Endocrinology consultation at 10 de Octubre hospital. These subjects underwent determination of TSH, total cholesterol, LDL cholesterol, cholesterol HDL, triglycerides. They got carotid ultrasound at the beginning of the study and one year after achieving euthyroid status with replacement treatment, to establish differences in the parameters evaluated before and after replacement treatment. Results: Prior to treatment, hypercholesterolemia was found in 87.2 percent of patients and hypertriglyceridemia in 38.3 percent, while elevated LDL cholesterol and decreased HDL cholesterol values were found in 55.3 percent and 19. .3 percent of them, CIMT was within the normal range. After treatment with levothyroxine, all the mean values of the parameters studied were modified, except in the case of triglycerides. Conclusions: Subclinical hypothyroidism replacement therapy has beneficial effects on CIMT, which could be secondary, among other factors, to the improvement of the lipid profile(AU)


Subject(s)
Humans , Male , Female , Carotid Artery Diseases/epidemiology , Carotid Intima-Media Thickness , Hypothyroidism/drug therapy , Hypothyroidism/epidemiology
10.
Rev. venez. cir ; 75(1): 45-48, ene. 2022. ilus
Article in Spanish | LILACS, LIVECS | ID: biblio-1391723

ABSTRACT

Las neoplasias quísticas pancreáticas se observan en cuerpo y cola del páncreas en mujeres de mediana edad. Son consideradas lesiones premalignas y requieren extirpación quirúrgica según tamaño y características imagenológicas. El cistoadenoma mucinoso es una neoplasia epitelial que produce mucina, forma quistes que surgen del páncreas y puede progresar a carcinoma invasivo. Representan la mitad de las neoplasias quísticas del páncreas. Lesiones sintomáticas en pacientes operables deben resecarse. En caso de lesiones asintomáticas, es importante diferenciar su estirpe (serosa o mucinosa) y su riesgo de degeneración. Una vez valorado el paciente, se indica tratamiento quirúrgico u observación. Caso clínico: Paciente femenina de 43 años con antecedentes de hipertensión arterial sistémica e hipotiroidismo controlados, quien presenta cuadro clínico caracterizado por distensión abdominal y síntomas dispépticos. Se realiza ultrasonografía abdominal y tomografía de abdomen y pelvis con doble contraste evidenciándose lesión redondeada hipodensa en rango líquido con septos finos en su interior, definida, que impresiona formar parte de cuerpo y cola de páncreas. Se decide resolución quirúrgica mediante laparotomía exploradora. Informe histopatológico: cistoadenoma mucinoso cuerpo y cola de páncreas. Conclusión: Las neoplasias quísticas del páncreas son tumoraciones que en la actualidad gracias al desarrollo de nuevas tecnologías se observan en nuestra práctica médica con más frecuencia. Al sospechar una neoplasia quística del páncreas, el tratamiento adecuado es la resección quirúrgica adaptada a la localización del tumor. El manejo de esta patología debe ser individualizado de acuerdo a las características clínicas, imagenológicas e histopatológicas del mismo(AU)


Pancreatic cystic neoplasms are observed in the body and tail of the pancreas in middle-aged women. They are considered premalignant lesions and require surgical removal depending on their size and imaging characteristics. Mucinous cystadenoma is an epithelial neoplasm that produces mucin, forms cysts that arise from the pancreas, and can progress to invasive carcinoma. They represent half of the cystic neoplasms of the pancreas. Symptomatic lesions in operable patients should be resected. In the case of asymptomatic lesions, it is important to differentiate their type (serous or mucinous) and their risk of degeneration. Once the patient has been assessed, surgical treatment or observation is indicated. Clinical case: A 43-year-old female patient with a history of controlled systemic arterial hypertension and hypothyroidism, who presented a clinical picture characterized by abdominal distension and dyspeptic symptoms. Abdominal ultrasonography and tomography of the abdomen and pelvis with double contrast were performed, a rounded, hypodense lesion in the liquid range with fine septa inside, defined, which appears to be part of the body and tail of the pancreas. Surgical resolution was decided by exploratory laparotomy. Histopathological report: mucinous cystadenoma of the body and tail of the pancreas. Conclusion: Cystic neoplasms of the pancreas are tumors that today, thanks to the development of new technologies, are observed more frequently in our medical practice. When suspecting a cystic neoplasm of the pancreas, the appropriate treatment is surgical resection adapted to the location of the tumor. The management of this pathology must be individualized according to its clinical, imaging and histopathological characteristics(AU)


Subject(s)
Humans , Female , Adult , Pancreas , Pancreatic Neoplasms , Cystadenoma, Mucinous , Pancreatectomy , Hypertension , Hypothyroidism , Laparotomy
11.
Article in Chinese | WPRIM | ID: wpr-927418

ABSTRACT

OBJECTIVE@#To observe the effect of wheat-grain moxibustion on behavior, 5-hydroxytryptamine (5-HT) and cortisol in the serum, mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the hippocampus in rats with hypothyroidism complicated with depression, and to explore the possible mechanism of wheat-grain moxibustion on improving depression in rats with hypothyroidism.@*METHODS@#A total of 32 SPF SD rats were randomly divided into a blank group, a model group, a medication group and a wheat-grain moxibustion group, 8 rats in each group. Except for the blank group, the rats in the remaining groups were treated with intragastric administration of 0.1% propylthiouracil (PTU) suspension at 1 mL/100 g, once a day for 4 weeks to establish the rat model of hypothyroidism, and whether the rats were accompanied with depression-like behavior determined through behavioristics evaluation. The rats in the medication group were intervened with euthyrox at 0.9 mL/100 g, once a day, for 4 weeks; the rats in the wheat-grain moxibustion group were treated with wheat-grain moxibustion at "Dazhui" (GV 14), "Mingmen" (GV 4), "Shenshu" (BL 23) and "Pishu" (BL 20), 7 cones each acupoint, once a day, six times a week for 4 weeks. After the intervention, the depression status was observed by behavioristics test; the contents of thyroid stimulating hormone (TSH), total thyroxine (TT4), 5-HT and cortisol in the serum were detected by ELISA; the protein expressions of MR and GR in hippocampus were detected by Western blot; the expressions of MR mRNA and GR mRNA in the hippocampus were detected by real-time PCR.@*RESULTS@#Before the intervention, compared with the blank group, the scores of open field test (OFT) were decreased and the immobility time of tail suspension test (TST) was prolonged (P<0.05); the serum TSH contents were increased and TT4 contents were decreased (P<0.01) in the other three groups. After the intervention, compared with the model group, the vertical score of OFT was increased and the immobility time of forced swimming test (FST) was prolonged in the medication group (P<0.05), while the scores of three items of OFT were increased (P<0.05, P<0.01), and the immobility time of FST and TST was shortened in the wheat-grain moxibustion group (P<0.01, P<0.05). Compared with the medication group, the immobility time of TST and FST in the wheat-grain moxibustion group was shorter (P<0.05, P<0.01). Compared with the blank group, in the model group, the contents of serum TSH and cortisol were increased (P<0.01, P<0.001), while the contents of serum TT4 and 5-HT were decreased (P<0.01, P<0.001). Compared with the model group, the contents of serum TT4 and 5-HT were increased, while the contents of serum TSH and cortisol were decreased in the medication group and wheat-grain moxibustion group (P<0.01, P<0.05). Compared with the blank group, the protein and mRNA expression of MR, GR in the hippocampus in the model group was decreased (P<0.01, P<0.05, P<0.001); compared with the model group, the protein and mRNA expression of MR in the hippocampus in the medication group were increased (P<0.05), and the protein expression of MR, GR and mRNA expression of MR in the hippocampus in the wheat-grain moxibustion group were increased (P<0.05, P<0.01). Compared with the medication group, the expression of MR mRNA in the wheat-grain moxibustion group was increased (P<0.05).@*CONCLUSION@#Wheat-grain moxibustion could significantly improve thyroid function and depression in rats with hypothyroidism. Its mechanism may be related to up-regulating the protein and mRNA expression of MR and GR in the hippocampus, and then affecting the expression of serum cortisol and 5-HT.


Subject(s)
Animals , Rats , Acupuncture Points , Depression/therapy , Hippocampus/metabolism , Hydrocortisone/metabolism , Hypothyroidism/therapy , Moxibustion , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/metabolism , Serotonin , Thyrotropin/metabolism , Triticum/metabolism
12.
Evid. actual. práct. ambul ; 25(1): e2087, 2022.
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1367592

ABSTRACT

Un estudio mostró que el aumento de valores de la hormona estimulante de la tiroides se asoció a un aumento de mortalidad por todas las causas, estimando que las enfermedades cardiovasculares mediaban dicha asociación en aproximada-mente el 14 % de los casos. Asimismo se observó que el reemplazo con levotiroxina disminuiría los niveles de colesterol, lo cual podría tener un efecto en la reducción de enfermedades cardiovasculares. Partiendo de una viñeta clínica la autora intenta, a través de una búsqueda bibliográfica y análisis de la evidencia, determinar si el tratamiento del hipotiroidismo subclínico en adultos mayores reduciría la morbimortalidad por eventos cardiovasculares. (AU)


A study showed that increased thyroid-stimulating hormone levels were associated with increased all-cause mortality, with cardiovascular disease estimated to mediate this association in approximately 14 % of cases. Additionally, levothyroxine replacement was found to lower cholesterol levels, which could have an effect in reducing cardiovascular diseases. Basedon a clinical vignette, the author attempts, through a literature search and an analysis of the evidence, to determine whether treatment of subclinical hypothyroidism in older adults would reduce morbidity and mortality from cardiovascular events. (AU)


Subject(s)
Humans , Female , Aged , Thyroxine/therapeutic use , Cardiovascular Diseases/mortality , Cardiovascular Diseases/prevention & control , Hypothyroidism/drug therapy , Indicators of Morbidity and Mortality , Age Factors , Hypothyroidism/blood
13.
Article in English | WPRIM | ID: wpr-962054

ABSTRACT

Objective@#To evaluate the status of euthyroidism achieved among Thai patients with post-ablative hypothyroidism and to examine the difference between various weight-based daily levothyroxine (LT4) replacement regimens in these patients.@*Methodology@#We conducted a retrospective review of Thai patients with Graves’ disease (GD) who developed hypothyroidism following radioactive iodine treatment from 2016 to 2020 at Theptarin hospital. Daily LT4 dose was calculated based on actual body weight (ABW), ideal body weight (IBW), and estimated lean body mass (LBM).@*Results@#We reviewed a total of 271 patient records. Of these, 81.2% were females with a mean age of 40.8±11.7 years, LT4 intake duration of 27.1±14.6 months, and LT4 dose/kg ABW of 1.4±0.5 μg/kg/day. At the final follow-up, 62.4% of patients achieved thyroid-stimulating hormone (TSH) levels within the reference interval, 15.5% had TSH levels over, and 22.1% had TSH levels under the reference range. Obese patients required a lower daily LT4 dose relative to ABW and higher daily LT4 dose relative to IBW to attain euthyroidism (ABW 1.1±0.4 μg/kg/day and IBW 2.0±0.8 μg/kg/day). Estimated daily LT4 dose based on LBM showed a constant dosage of 2.0 μg/kg/day in all BMI categories.@*Conclusions@#Suboptimum LT4 replacement therapy was found in almost half of hypothyroid patients with GD treated with radioactive iodine. Estimated LBM was a better indicator for dosing calculation in these patients compared with ABW and IBW.


Subject(s)
Hypothyroidism
14.
Rev. chil. endocrinol. diabetes ; 15(2): 71-74, 2022.
Article in Spanish | LILACS | ID: biblio-1391811

ABSTRACT

INTRODUCCIÓN Y OBJETIVO: El hipotiroidismo es una condición frecuente en mujeres en Chile. Existe evidencia contundente de una fuerte asociación entre esta patología e infertilidad femenina. El objetivo de esta revisión es resumir los principales mecanismos fisiopatológicos descritos en la literatura que explicarían la infertilidad femenina en mujeres hipotiroideas. MÉTODOS: Se llevó a cabo una búsqueda bibliográfica por medio PubMed con los términos: hipotiroidismo, infertilidad y fisiopatología. De todos los artículos se seleccionaron únicamente los correspondientes a población femenina. Incluimos tanto hipotiroidismo clínico como subclínico, y mujeres eutiroideas con anti-TPO (+). RESULTADOS: Clasificamos la literatura disponible en tres grupos de mecanismo fisiopatológicos. En primer lugar, la deficiencia de hormonas tiroideas T3 y T4 producirían alteraciones en la foliculogénesis, ovulación, implantación y placentación. En segundo lugar, la hiperprolactinemia secundaria al hipotiroidismo llevaría a un hipogonadismo hipogonadotrópico e insuficiencia en la fase lútea. En tercer lugar, los anticuerpos anti-TPO, independientemente de los niveles de hormonas tiroideas, podrían tener una reacción cruzada con proteínas presentes en el útero, afectando el proceso de implantación. CONCLUSIONES: El hipotiroidismo produce infertilidad femenina por variados mecanismos fisiopatológicos. Dada la variabilidad de estos, existe un mayor espectro de aproximaciones terapéuticas para tratar mujeres hipotiroideas con problemas de fertilidad.


INTRODUCTION AND OBJECTIVE: Hypothyroidism is a frequent condition in Chile in women in Chile. There is strong evidence of an association between this pathology and feminine infertility. The objective of this review is to summarize the main physiopathological mechanisms described in the literature that explain infertility in women with hypothyroidism. METHODS: We performed a bibliographic search on PubMed with the terms: hypothyroidism, infertility, physiopathology. Among all the articles we selected only the ones regarding to feminine population. We included both clinical and subclinical hypothyroidism, and euthyroid women with Anti-TPO (+). RESULTS: We classified the available literature into three groups of physiological mechanisms. In the first place, decreased thyroid hormones T3 and T4 may lead to alterations on folliculogenesis, ovulation, implantation and placentation. Secondly, hyperprolactinemia secondary to hypothyroidism would produce hypogonadotropic hypogonadism and luteal phase insufficiency. Thirdly, anti-TPO antibodies, independently on thyroid hormones levels, may have a cross reactivity towards proteins in the womb, negatively affecting the process of implantation. CONCLUSIONS: Hypothyroidism produces infertility through varied physiopathological mechanisms. Due to their variability, there is a wider scope for therapeutical approaches to treat women with hypothyroidism and fertility problems.


Subject(s)
Humans , Female , Hypothyroidism/physiopathology , Infertility, Female
15.
Braz. dent. sci ; 25(1): 1-7, 2022. tab, ilus
Article in English | LILACS, BBO | ID: biblio-1354491

ABSTRACT

Objective: Recent investigations have suggested a correlation between thyroid diseases, particularly hypothyroidism (HT), and oral lichen planus (OLP). Objective: This study aimed to assess the frequency of OLP in HT patients. Material and Methods: This analytical descriptive study evaluated 100 HT patients including 94 females and 6 males, who were selected by convenience sampling. The subjects were clinically examined for OLP. The mean age of patients was 42.49±1.29 years. Also, 100 age- and sex-matched healthy controls were examined. The data were analyzed using chi-square test and Fisher's exact test via SPSS. Results: Of all, 14 (14%) HT patients (12 females and 2 males) had OLP while only one case of OLP was found in the control group. The difference between the two groups in the frequency of OLP was significant (P=0.001). The odds ratio (OR) of developing OLP was calculated to be 16.11 in HT patients. Reticular form was the most common type of OLP in patients (50%). The buccal mucosa was the most common site of involvement (92.85%). The mean age of patients with OLP was 42.93±1.29 years with a median of 46±1.29 years in HT group. Conclusion: The frequency of OLP was significantly higher in HT patients such that HT patients had higher odds of developing OLP by 16 folds. (AU)


Objetivo: Investigações recentes sugeriram uma correlação entre doenças da tireoide, particularmente hipotireoidismo (HT), e líquen plano oral (LPO). Objetivo: Este estudo teve como objetivo avaliar a frequência de LPO em pacientes com HT. Material e Métodos: Este estudo descritivo analítico avaliou 100 pacientes com HT, incluindo 94 mulheres e 6 homens, selecionados por amostragem por conveniência. Os indivíduos foram examinados clinicamente para LPO. A média de idade dos pacientes foi de 42,49 ± 1,29 anos. Além disso, foram examinados 100 controles saudáveis pareados por idade e gênero. Os dados foram analisados usando o teste do qui-quadrado e o teste exato de Fisher via SPSS. Resultados: De todos, 14 (14%) pacientes com HT (12 mulheres e 2 homens) tiveram LPO, enquanto apenas um caso de LPO foi encontrado no grupo controle. A diferença entre os dois grupos na frequência de LPO foi significativa (P = 0,001). A razão de probabilidade de desenvolvimento de LPO foi calculado em 16,11 em pacientes com HT. A forma reticular foi o tipo mais comum de LPO nos pacientes (50%). A mucosa bucal foi o local de acometimento mais comum (92,85%). A média de idade dos pacientes com LPO foi de 42,93 ± 1,29 anos, com mediana de 46 ± 1,29 anos no grupo HT. Conclusão: A frequência de LPO foi significativamente maior em pacientes com HT, de modo que os pacientes com HT tinham maior chance de desenvolver LPO em 16 vezes. (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Thyroid Diseases , Lichen Planus, Oral , Hypothyroidism
17.
Rev. Soc. Bras. Clín. Méd ; 20(2): 120-122, 2022.
Article in Portuguese | LILACS | ID: biblio-1428755

ABSTRACT

A hiperplasia hipofisária é definida como um aumento não neoplásico no número de um dos tipos de células presentes na hipófise. Ela pode ocorrer por um processo fisiológico ou patológico. O hipotireoidismo primário prolongado é uma das causas patológicas desta condição, e ocorre devido a perda do feedback negativo. O objetivo desse relato foi demonstrar a presença de hiperplasia hipofisária em um paciente masculino com características corporais sugestivas de acromegalia. A investigação laboratorial confirmou a presença de hipotireoidismo primário e descartou a acromegalia. Foi instituído tratamento com levotiroxina, levando a regressão da hiperplasia hipofisária. Esse caso ilustra a importância de uma investigação apropriada em pacientes com hiperplasia hipofisária, bem como discute a fisiopatologia e o tratamento dessa doença.


Pituitary hyperplasia is defined as a non-neoplastic increase in the number of one of the cell types present in the pituitary gland. It can occur by a physiological or pathological process. Prolonged primary hypothyroidism is one of the pathological causes of this condition and occurs due to the lack of negative feedback. The objective of this report was to demonstrate the presence of pituitary hyperplasia in a male patient with body characteristics suggestive of acromegaly. Laboratory investigation confirmed the presence of primary hypothyroidism and ruled out acromegaly. Treatment with levothyroxine was instituted, leading to regression of pituitary hyperplasia. This case illustrates the importance of an appropriate investigation in patients with pituitary hyperplasia, as well as discussing the pathophysiology and treatment of this disease.


Subject(s)
Humans , Male , Pituitary Gland/pathology , Hyperplasia/etiology , Hypothyroidism/complications , Thyroxine/therapeutic use , Thyrotrophs , Hypothyroidism/drug therapy
18.
Med. lab ; 26(1): 11-13, 2022.
Article in Spanish | LILACS | ID: biblio-1370943

ABSTRACT

La enfermedad tiroidea, junto con la diabetes mellitus, son las dos endocrinopatías más frecuentes en el embarazo. El hipotiroidismo primario en mujeres en edad gestacional tiene una prevalencia del 2%, convirtiendo en un reto su diagnóstico, tratamiento y seguimiento en la práctica clínica


Thyroid disease, along with diabetes mellitus, are the two most common endocrinopathies in pregnancy. Primary hypothyroidism in women of gestational age has a prevalence of 2%, making its diagnosis, treatment and follow-up a challenge in clinical practice


Subject(s)
Thyroid Diseases , Pregnancy , Diabetes Mellitus , Endocrine System Diseases , Hypothyroidism
19.
Med. lab ; 26(1): 15-33, 2022. Tabs, ilus, Grafs
Article in Spanish | LILACS | ID: biblio-1370944

ABSTRACT

Durante el embarazo se generan múltiples cambios fisiológicos a nivel hormonal para llevar a cabo de manera satisfactoria la gestación. Uno de los ejes hormonales con cambios más importantes que repercuten de manera directa en el desarrollo fetal y bienestar materno es el tiroideo, el cual presenta modificaciones para lograr suplir las necesidades de hormona tiroidea tanto materna como fetal, principalmente en las primeras etapas del embarazo. Entre estas, se describen cambios en la cantidad de proteínas transportadoras de hormonas, aumento en el estímulo y producción de hormonas tiroideas, incremento del aclaramiento renal de yodo y alteración en la actividad de las desyodinasas. Estos mecanismos ofrecen suficiente hormona tiroidea al feto, el cual es dependiente del aporte materno. Un desajuste en cualquiera de estos mecanismos, puede conducir al desarrollo de hipotiroidismo con múltiples complicaciones, como la pérdida del embarazo e hipertensión gestacional, entre otras. Una tamización oportuna y un tratamiento temprano pueden evitar estos desenlaces adversos. De ahí la necesidad fundamental de conocer y comprender el comportamiento del eje tiroideo en la gestación


During pregnancy, multiple physiological changes are generated at the hormonal level to successfully carry out pregnancy. One of the hormonal axes with the most important changes that have a direct impact on fetal development and maternal well-being is the thyroid axis, which presents multiple modifications to reach the needs of thyroid hormone for both the mother and the fetus, primarily in the early stages of pregnancy. Changes in the amount of hormone transport proteins, increased stimulation and production of thyroid hormones, increased renal clearance of iodine, and alteration in deiodinase activity are included within these modifications. These mechanisms offer enough thyroid hormone to the fetus, which is dependent on the maternal supply. An imbalance in any of these can lead to the development of hypothyroidism with multiple complications, such as pregnancy loss and gestational hypertension, among others. Timely screening and early treatment can avoid these adverse outcomes, hence the importance of knowing and understanding the regulation of the thyroid axis in pregnancy


Subject(s)
Humans , Thyroid Gland , Physiology , Pregnancy , Hypothyroidism
20.
BioSC. (Curitiba, Impresso) ; 80(Supl.1): 9-13, 20220000.
Article in Portuguese | LILACS | ID: biblio-1417631

ABSTRACT

O escore de Apgar avalia rapidamente o estado clínico de neonatos. A asfixia perinatal é uma das causas do baixo índice de Apgar e contribui significativamente com a morbimortalidade. Objetivo: Avaliar a prevalência do Apgar baixo no quinto minuto de vida e determinar o perfil epidemiológico desses pacientes. Método: É estudo retrospectivo transversal epidemiológico. Foram coletados os dados dos recém-nascidos vivos com Apgar 5' <7 de 2 anos. Excluiu-se pacientes com anomalias congênitas e 118 pacientes foram analisados. Resultados: A prevalência do Apgar 5' <7 foi de 21,47/1000. Sexo masculino, nascimento a termo e por cesárea, apresentação cefálica, bolsa rota no ato, gestações simples, mães entre 20 e 34 anos com hipotireoidismo e diabetes, em uso de medicação, e mais de 6 consultas de pré-natal foram a maioria dentre os fatores analisados. Do total, 33,9% eram pré-termo; 30,5% tinham baixo peso; 24% apresentaram líquido amniótico meconial; 16% distócia; e 13% circular de cordão. Conclusão: A prevalência do Apgar 5' <7 foi de 21,47/1000. O perfil epidemiológico dentre os fatores analisados foi sexo masculino, nascimento a termo e por cesárea, apresentação cefálica, bolsa rota no ato, gestações simples, mães entre 20-34 anos com hipotireoidismo e diabete, em uso de medicação, e mais de 6 consultas de pré-natal


The Apgar score quickly assesses the clinical status of neonates. Perinatal asphyxia is one of the causes of low Apgar scores and contributes significantly to neonatal morbidity and mortality. Objective: To evaluate the prevalence of low Apgar in the fifth minute of life and to determine the epidemiological profile of these patients. Method: It is a retrospective cross-sectional epidemiological study. Data were collected from live newborns with Apgar5' <7 over 2 years. Patients with congenital anomalies were excluded, and 118 patients were analyzed. Results: The prevalence of Apgar 5' <7 was 21.47/1000. Male, full-term and cesarean delivery, cephalic presentation, water breaking during labor, singlet pregnancies, mothers between 20 and 34 years old with hypothyroidism and diabetes, using medication, and more than 6 prenatal consultations were the majority among the analyzed factors; 33.9% were preterm; 30.5% underweight; 24% had meconium-stained amniotic fluid; 16% dystocia and 13% nuchal cord. Conclusion: The prevalence of Apgar 5' <7 was 21.47/1000. The epidemiological profile among the analyzed factors was male gender, full-term birth and by cesarean section, cephalic presentation, ruptured water at the moment, simple pregnancies, mothers between 20-34 years old with hypothyroidism and diabetes, using medication, and more than 6 consultations of prenatal care


Subject(s)
Humans , Infant, Newborn , Apgar Score , Asphyxia Neonatorum , Health Profile , Infant, Newborn , Prenatal Care , Cesarean Section , Diabetes Mellitus , Hypothyroidism
SELECTION OF CITATIONS
SEARCH DETAIL